SBRT With Atezo/Bev for HCC

Clinical trial NCT05488522 · RECRUITING

Trial details

NCT number: NCT05488522
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2022-09-01
Primary completion: 2026-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.